vitaminas y minerales
vitaminas y minerales
vitaminas y minerales
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Natural Solutions Foundation<br />
www.HealthFreedomUSA.org ; naturalsolutions@optionline.net<br />
Triglicéridos Séricos: el alcohol y los azúcares simples son de fuentes con bajos niveles de fibra<br />
que pueden elevar los triglicéridos. Por otra parte, este factor de riesgo cardiovascular es muy<br />
sensible a las estrategias alimentarias que incluyen la suplementación con:<br />
• Aceite de pescado 201<br />
• Inositol 202 , 203 , 204<br />
• Té Verde (4 tazas o equivalente) 205<br />
• Colina 206 , 207<br />
• Niacina (vitamina B3) 208 , 209<br />
• Pantetina 210 , 211 , 212<br />
• Cromo 213 , 214 , 215 , 216 , 217<br />
201 Prichard BN, Smith CCT, Ling KLE, Betteridge DJ. Fish oils and cardiovascular disease. BMJ 1995;310:819–20<br />
[editorial/review].<br />
202 Brown WV. Niacin for lipid disorders. Postgrad Med 1995; 98:183–93 [review]<br />
203 Head KA. Inositol hexaniacinate: a safer alternative to niacin. Altern Med Rev 1996;1:176–84 [review]<br />
204 Murray M. Lipid-lowering drugs vs. inositol hexaniacinate. Am J Natural Med 1995;2(8):9–12 [review]<br />
205 Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ<br />
1995;310:693–6.<br />
206 Buchman, Alan L, Ament, Marvin E, Sohel, Mir, Dubin, Mark, Et al, Choline deficiency causes reversible hepatic<br />
abnormalities in patients receiving parenteral nutrition: Proof of a human choline requirement: A placebo-controlled trial,<br />
JPEN, Sep/Oct 2001<br />
207 Watkins SM, Zhu X, Zeisel SH., Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate<br />
liver-plasma lipid flux and essential fatty acid metabolism in mice. J Nutr. 2003 Nov;133(11):3386-9<br />
208 Berra K. , Clinical update on the use of niacin for the treatment of dyslipidemia. J Am Acad Nurse Pract. 2004<br />
Dec;16(12):526-34.<br />
209 Shepherd J, Betteridge J, Van Gaal L; European Consensus Panel, Nicotinic acid in the management of<br />
dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus<br />
Panel. Curr Med Res Opin. 2005 May;21(5):665-82.<br />
210 Arsenio L, Bodria P, Magnati G, et al. Effectiveness of long-term treatment with pantethine in patients with<br />
dyslipidemia. Clin Ther 1986;8:537–45.<br />
211 Avogaro P, Bon GB, Fusello M. Effect of pantethine on lipids, lipoproteins and apolipoproteins in man. Curr Ther Res<br />
1983;33:488–93.<br />
212 Maggi GC, Donati C, Criscuoli G. Pantethine: a physiological lipomodulating agent, in the treatment of<br />
hyperlipidemias. Curr Ther Res 1982;32:380–6.<br />
213 Uusitupa MI, Kumpulainen JT, Voutilainen E, et al. Effect of inorganic chromium supplementation on glucose<br />
tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr 1983;38:404–10<br />
214 Hermann J, Chung H, Arquitt A, et al. Effects of chromium or copper supplementation on plasma lipids, plasma<br />
glucose and serum insulin in adults over age fifty. J Nutr Elderly 1998;18:27–45.<br />
215 Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes<br />
Care 1994;17:1449–52.<br />
94